Sara C Handley1, Molly Passarella2, Henry C Lee3, Scott A Lorch4. 1. Department of Pediatrics, Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA. Electronic address: handleys@email.chop.edu. 2. Department of Pediatrics, Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA; Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA. 3. Department of Pediatrics, Division of Neonatal & Developmental Medicine, Stanford University, Stanford, CA; California Perinatal Quality Care Collaborative (CPQCC), Stanford, CA. 4. Department of Pediatrics, Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, PA; Center for Perinatal and Pediatric Health Disparities Research, The Children's Hospital of Philadelphia, Philadelphia, PA; Leonard Davis Institute of Health Economics, The Wharton School, The University of Pennsylvania, Philadelphia, PA.
Abstract
OBJECTIVE: To quantify the current burden of severe intraventricular hemorrhage (IVH), describe time trends in severe IVH, identify IVH-associated risk factors, and determine the contribution of mediating factors. STUDY DESIGN: The retrospective cohort included infants 220/7-316/7 weeks of gestation without severe congenital anomalies, born at hospitals in the California Perinatal Quality Care Collaborative between 2005 and 2015. The primary study outcome was severe (grade III or IV) IVH. RESULTS: Of 44 028 infants, 3371 (7.7%) had severe IVH. The incidence of severe IVH decreased significantly across California from 9.7% in 2005 to 5.9% in 2015. After stratification by gestational age, antenatal steroid exposure was the only factor associated with a decreased odds of severe IVH for all gestational age subgroups. Other factors, including delivery room intubation, were associated with an increased odds of severe IVH, though significance varied by gestational age. Factors analyzed in the mediation analysis accounted for 45.6% (95% CI 38.7%-71.8%) of the reduction in severe IVH, with increased antenatal steroid administration and decreased delivery room intubation mediating a significant proportion of this decrease, 19.4% (95% CI 13.9%-27.5%) and 27.3% (95% CI 20.3%-39.2%), respectively. The unaccounted proportion varied by gestational age. CONCLUSIONS: The incidence of severe IVH decreased across California, associated with changes in antenatal steroid exposure and delivery room intubation. Maternal, patient, and delivery room factors accounted for less than one-half of the decrease in severe IVH. Study of other factors, specifically neonatal intensive care unit and hospital-level factors, may provide new insights into policies to reduce severe IVH.
OBJECTIVE: To quantify the current burden of severe intraventricular hemorrhage (IVH), describe time trends in severe IVH, identify IVH-associated risk factors, and determine the contribution of mediating factors. STUDY DESIGN: The retrospective cohort included infants 220/7-316/7 weeks of gestation without severe congenital anomalies, born at hospitals in the California Perinatal Quality Care Collaborative between 2005 and 2015. The primary study outcome was severe (grade III or IV) IVH. RESULTS: Of 44 028 infants, 3371 (7.7%) had severe IVH. The incidence of severe IVH decreased significantly across California from 9.7% in 2005 to 5.9% in 2015. After stratification by gestational age, antenatal steroid exposure was the only factor associated with a decreased odds of severe IVH for all gestational age subgroups. Other factors, including delivery room intubation, were associated with an increased odds of severe IVH, though significance varied by gestational age. Factors analyzed in the mediation analysis accounted for 45.6% (95% CI 38.7%-71.8%) of the reduction in severe IVH, with increased antenatal steroid administration and decreased delivery room intubation mediating a significant proportion of this decrease, 19.4% (95% CI 13.9%-27.5%) and 27.3% (95% CI 20.3%-39.2%), respectively. The unaccounted proportion varied by gestational age. CONCLUSIONS: The incidence of severe IVH decreased across California, associated with changes in antenatal steroid exposure and delivery room intubation. Maternal, patient, and delivery room factors accounted for less than one-half of the decrease in severe IVH. Study of other factors, specifically neonatal intensive care unit and hospital-level factors, may provide new insights into policies to reduce severe IVH.
Authors: Henry C Lee; Richard J Powers; Mihoko V Bennett; Neil N Finer; Louis P Halamek; Courtney Nisbet; Margaret Crockett; Kathy Chance; David Blackney; Connie von Köhler; Paul Kurtin; Paul J Sharek Journal: Pediatrics Date: 2014-10-20 Impact factor: 7.124
Authors: Charles W Sauer; Juin Yee Kong; Yvonne E Vaucher; Neil Finer; James A Proudfoot; Mallory A Boutin; Tina A Leone Journal: J Pediatr Date: 2016-07-26 Impact factor: 4.406
Authors: T Michael O'Shea; Elizabeth N Allred; Karl C K Kuban; Deborah Hirtz; Barbara Specter; Sara Durfee; Nigel Paneth; Alan Leviton Journal: J Child Neurol Date: 2012-01 Impact factor: 1.987
Authors: Rachana Singh; Samuel V Gorstein; Frank Bednarek; Joseph H Chou; Elisabeth C McGowan; Paul F Visintainer Journal: Sci Rep Date: 2013 Impact factor: 4.379
Authors: Nansi S Boghossian; Marco Geraci; Scott A Lorch; Ciaran S Phibbs; Erika M Edwards; Jeffrey D Horbar Journal: Pediatrics Date: 2019-08-12 Impact factor: 7.124
Authors: Jacob Gluski; Paul Zajciw; Prashant Hariharan; Amanda Morgan; Diego M Morales; Andrew Jea; William Whitehead; Neena Marupudi; Steven Ham; Sandeep Sood; James P McAllister; David D Limbrick; Carolyn A Harris Journal: Fluids Barriers CNS Date: 2020-07-18
Authors: Olga Romantsik; Alex Adusei Agyemang; Snjolaug Sveinsdóttir; Sigurbjörg Rutardóttir; Bo Holmqvist; Magnus Cinthio; Mattias Mörgelin; Gulcin Gumus; Helena Karlsson; Stefan R Hansson; Bo Åkerström; David Ley; Magnus Gram Journal: J Neuroinflammation Date: 2019-06-07 Impact factor: 8.322
Authors: Amanda Kristiansson; Magnus Gram; Johan Flygare; Stefan R Hansson; Bo Åkerström; Jill R Storry Journal: Int J Mol Sci Date: 2020-09-30 Impact factor: 5.923